- Home
- RANI vs PVL Comparison
RANI vs PVL Comparison
Compare RANI & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RANI
- PVL
- Stock Information
- Founded
- RANI 2012
- PVL 2011
- Country
- RANI United States
- PVL United States
- Employees
- RANI N/A
- PVL N/A
- Industry
- RANI Medicinal Chemicals and Botanical Products
- PVL Oil & Gas Production
- Sector
- RANI Health Care
- PVL Energy
- Exchange
- RANI Nasdaq
- PVL Nasdaq
- Market Cap
- RANI 55.3M
- PVL 45.5M
- IPO Year
- RANI 2021
- PVL N/A
- Fundamental
- Price
- RANI $1.27
- PVL $1.57
- Analyst Decision
- RANI Strong Buy
- PVL
- Analyst Count
- RANI 6
- PVL 0
- Target Price
- RANI $11.33
- PVL N/A
- AVG Volume (30 Days)
- RANI 147.7K
- PVL 61.4K
- Earning Date
- RANI 05-05-2025
- PVL 01-01-0001
- Dividend Yield
- RANI N/A
- PVL 6.01%
- EPS Growth
- RANI N/A
- PVL N/A
- EPS
- RANI N/A
- PVL 0.09
- Revenue
- RANI N/A
- PVL $4,339,313.00
- Revenue This Year
- RANI N/A
- PVL N/A
- Revenue Next Year
- RANI N/A
- PVL N/A
- P/E Ratio
- RANI N/A
- PVL $18.25
- Revenue Growth
- RANI N/A
- PVL N/A
- 52 Week Low
- RANI $1.24
- PVL $1.03
- 52 Week High
- RANI $8.75
- PVL $1.96
- Technical
- Relative Strength Index (RSI)
- RANI 37.10
- PVL 60.10
- Support Level
- RANI $1.30
- PVL $1.47
- Resistance Level
- RANI $1.56
- PVL $1.57
- Average True Range (ATR)
- RANI 0.09
- PVL 0.04
- MACD
- RANI -0.02
- PVL 0.00
- Stochastic Oscillator
- RANI 16.06
- PVL 73.08
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.
About PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production the sale of oil and natural gas production from primarily non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.